Prudential Financial, Inc. 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-08 11:21 am Sale | 2026-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | PRUDENTIAL FINANCIAL INC PRU | 1,836,321 4.300% | -459,079 (-20.00%) | Filing |
| 2024-11-14 4:41 pm Purchase | 2024-11-14 | 13G | TARSUS PHARMACEUTICALS INC TARS | PRUDENTIAL FINANCIAL INC PRU | 2,295,400 6.000% | 2,295,400 (New Position) | Filing |